Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone
- Status
- SUSPENDED
- Phase
- PHASE2
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
- Status
- TERMINATED
- Phase
- PHASE1
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
- Status
- TERMINATED
- Phase
- PHASE4
Circulating Tumor Cells and Tumor DNA in HCC and NET
- Status
- COMPLETED
- Phase
- N/A
Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- NA
A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease
- Status
- COMPLETED
- Phase
- PHASE2
De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
- Status
- COMPLETED
- Phase
- PHASE1
Palbociclib With Everolimus + Exemestane In BC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2